Transplantation Market Trends, Size, Growth, and Forecast 2023-2028

Comments · 61 Views

The market expects to reach US$ 26.6 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028.

The "Transplantation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report by IMARC Group offers a detailed analysis of the industry, including transplantation market share, size, demand, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the Transplantation Market?

The global transplantation market size reached US$ 14.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 26.6 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028.

What is Transplantation?

Transplantation is a medical procedure that involves the transfer of organs or tissues from one individual to another, in order to replace or repair damaged or diseased organs or tissues. It is done to improve or restore the function of the recipient's body, allowing them to live a healthier and longer life. It is performed when the recipient's organ or tissue fails, usually due to illness, injury, or congenital defects. It is majorly performed on the heart, kidneys, liver, lungs, pancreas, skin, bone and corneas. In order for transplantation to be successful, the donor and recipient must be carefully matched to minimize the risk of rejection, in which the recipient's immune system attacks the transplanted organ or tissue. Immunosuppressive drugs are often used to prevent rejection, although they can have side effects and increase the risk of infections.

Get Free Sample Copy of Report at –

What are the Growth Prospects and Trends in the Transplantation Market?

The escalating healthcare expenditure majorly drives the global market. This can be supported by the growing prevalence of chronic diseases and the growing geriatric population. Along with this, the increasing number of organ failures due to acute diseases, severe trauma, drug abuse, sepsis, and other factors, along with lifestyle disorders caused by unhealthy habits, including smoking, alcohol consumption, and physical inactivity, is contributing to the demand for transplantation among the masses. In addition, the growing public awareness of medical advancements and a shortage of organ donors further supporting the market. Moreover, continual technological advancements, such as the introduction of 3D bioprinting, decellularization, and interspecies organogenesis, are creating a positive market outlook. Some of the other factors driving the market include the rapid expansion of tissue banks and continual improvements in healthcare infrastructure.

Who are the key Players Operating in the Industry?

  • 21st Century Medicine
  • AbbVie Inc.
  • Arthrex Inc.
  • Astellas Pharma Inc.
  • BioLife Solutions Inc.
  • CareDx Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • TransMedics Inc.
  • Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

What is included in Market Segmentation?

The report has segmented the market into the following categories:

Product Insights:

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solution

Application Insights:

  • Organ Transplantation
  • Tissue Transplantation

End User Insights:

  • Hospitals
  • Transplantation Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

  • Market Performance 
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:


134 N 4th St. Brooklyn, NY 11249, USA


Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Read more